These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27530731)

  • 1. Plumbagin Enhances Tamoxifen Sensitivity and Inhibits Tumor Invasion in Endocrine Resistant Breast Cancer through EMT Regulation.
    Sakunrangsit N; Kalpongnukul N; Pisitkun T; Ketchart W
    Phytother Res; 2016 Dec; 30(12):1968-1977. PubMed ID: 27530731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NADPH: Quinone oxidoreductase 1 (NQO1) mediated anti-cancer effects of plumbagin in endocrine resistant MCF7 breast cancer cells.
    Pradubyat N; Sakunrangsit N; Mutirangura A; Ketchart W
    Phytomedicine; 2020 Jan; 66():153133. PubMed ID: 31790893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plumbagin inhibits cancer stem-like cells, angiogenesis and suppresses cell proliferation and invasion by targeting Wnt/β-catenin pathway in endocrine resistant breast cancer.
    Sakunrangsit N; Ketchart W
    Pharmacol Res; 2019 Dec; 150():104517. PubMed ID: 31693936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
    Qiu JX; Zhou ZW; He ZX; Zhao RJ; Zhang X; Yang L; Zhou SF; Mao ZF
    Drug Des Devel Ther; 2015; 9():349-417. PubMed ID: 25609920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plumbagin inhibited AKT signaling pathway in HER-2 overexpressed-endocrine resistant breast cancer cells.
    Sakunrangsit N; Ketchart W
    Eur J Pharmacol; 2020 Feb; 868():172878. PubMed ID: 31863768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plumbagin induces cell cycle arrest and autophagy and suppresses epithelial to mesenchymal transition involving PI3K/Akt/mTOR-mediated pathway in human pancreatic cancer cells.
    Wang F; Wang Q; Zhou ZW; Yu SN; Pan ST; He ZX; Zhang X; Wang D; Yang YX; Yang T; Sun T; Li M; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():537-60. PubMed ID: 25632222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
    Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
    Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential role of Notch4/STAT3 signaling in epithelial-mesenchymal transition of tamoxifen-resistant human breast cancer.
    Bui QT; Im JH; Jeong SB; Kim YM; Lim SC; Kim B; Kang KW
    Cancer Lett; 2017 Apr; 390():115-125. PubMed ID: 28108315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen-resistant breast cancer cells possess cancer stem-like cell properties.
    Liu H; Zhang HW; Sun XF; Guo XH; He YN; Cui SD; Fan QX
    Chin Med J (Engl); 2013 Aug; 126(16):3030-4. PubMed ID: 23981606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol sensitizes tamoxifen in antiestrogen-resistant breast cancer cells with epithelial-mesenchymal transition features.
    Shi XP; Miao S; Wu Y; Zhang W; Zhang XF; Ma HZ; Xin HL; Feng J; Wen AD; Li Y
    Int J Mol Sci; 2013 Jul; 14(8):15655-68. PubMed ID: 23896596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHP-1 inhibits cancer metastasis and restores topotecan sensitivity via regulating epithelial-mesenchymal transition and TGF-β signaling in human breast cancer cells.
    Lin S; Lyu X; Yu J; Sun L; Du D; Lai Y; Li H; Wang Y; Zhang L; Yin H; Yuan S
    Phytomedicine; 2016 Sep; 23(10):1053-63. PubMed ID: 27444351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer.
    Larsen SL; Yde CW; Laenkholm AV; Rasmussen BB; Duun-Henriksen AK; Bak M; Lykkesfeldt AE; Kirkegaard T
    BMC Cancer; 2015 Apr; 15():239. PubMed ID: 25885472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glyceollin I Reverses Epithelial to Mesenchymal Transition in Letrozole Resistant Breast Cancer through ZEB1.
    Carriere PP; Llopis SD; Naiki AC; Nguyen G; Phan T; Nguyen MM; Preyan LC; Yearby L; Pratt J; Burks H; Davenport IR; Nguyen TA; Parker-Lemieux K; Payton-Stewart F; Williams CC; Boué SM; Burow ME; Collins-Burow B; Hilliard A; Davidson AM; Tilghman SL
    Int J Environ Res Public Health; 2015 Dec; 13(1):ijerph13010010. PubMed ID: 26703648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-375 inhibits cancer stem cell phenotype and tamoxifen resistance by degrading HOXB3 in human ER-positive breast cancer.
    Fu H; Fu L; Xie C; Zuo WS; Liu YS; Zheng MZ; Yu JM
    Oncol Rep; 2017 Feb; 37(2):1093-1099. PubMed ID: 28075453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
    Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
    BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR inhibition reverses epithelial‑mesenchymal transition, and decreases tamoxifen resistance via Snail and Twist downregulation in breast cancer cells.
    Takeda T; Tsubaki M; Matsuda T; Kimura A; Jinushi M; Obana T; Takegami M; Nishida S
    Oncol Rep; 2022 Jun; 47(6):. PubMed ID: 35445730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen reverses epithelial-mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells.
    Wang Q; Cheng Y; Wang Y; Fan Y; Li C; Zhang Y; Wang Y; Dong Q; Ma Y; Teng YE; Qu X; Liu Y
    BMC Cancer; 2017 Jul; 17(1):492. PubMed ID: 28724364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory Effects of Plumbagin on Retinal Pigment Epithelial Cell Epithelial-Mesenchymal Transition In Vitro and In Vivo.
    Chen H; Wang H; An J; Shang Q; Ma J
    Med Sci Monit; 2018 Mar; 24():1502-1510. PubMed ID: 29532788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salinomycin overcomes acquired tamoxifen resistance through AIB1 and inhibits cancer cell invasion in endocrine resistant breast cancer.
    Manmuan S; Sakunrangsit N; Ketchart W
    Clin Exp Pharmacol Physiol; 2017 Oct; 44(10):1042-1052. PubMed ID: 28656701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-200b regulates epithelial-mesenchymal transition of chemo-resistant breast cancer cells by targeting FN1.
    Yang X; Hu Q; Hu LX; Lin XR; Liu JQ; Lin X; Dinglin XX; Zeng JY; Hu H; Luo ML; Yao HR
    Discov Med; 2017 Sep; 24(131):75-85. PubMed ID: 28972876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.